Shridhar Narayanan

Title: Shridhar Narayanan: Innovator in Cannabinoid Research

Introduction

Shridhar Narayanan is a notable inventor based in Thane, India. He has made significant contributions to the field of cannabinoid research, focusing on the development of novel pharmaceutical compositions. His work aims to address various medical conditions through innovative approaches.

Latest Patents

Narayanan holds 2 patents related to cannabinoid receptor ligands and their pharmaceutical applications. His latest patents include the development of cannabinoid receptor modulators, specifically targeting cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptors. These inventions are designed to treat diseases and disorders influenced by cannabinoid receptors, such as pain, neurodegenerative disorders, eating disorders, weight loss, and obesity.

Career Highlights

Narayanan is currently associated with Glenmark Pharmaceuticals S.A., where he continues to advance his research in cannabinoid therapeutics. His work has the potential to significantly impact the pharmaceutical industry and improve treatment options for patients suffering from various conditions.

Collaborations

Some of his notable coworkers include Meyyappan Muthuppalaniappan and Gopalan Balasubramanian. Their collaborative efforts contribute to the innovative research environment at Glenmark Pharmaceuticals.

Conclusion

Shridhar Narayanan's contributions to cannabinoid research exemplify the importance of innovation in the pharmaceutical field. His patents reflect a commitment to developing effective treatments for complex medical conditions.